HrQoL in hair loss‐affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety-Reference-Cited by-同舟云学术

HrQoL in hair loss‐affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety

Published:2018-12-02 Issue:3 Volume:33 Page:608-611
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Russo P.M.¹^ORCID,Fino E.¹^ORCID,Mancini C.²,Mazzetti M.¹^ORCID,Starace M.¹²^ORCID,Piraccini B.M.¹²^ORCID

Affiliation:

1. Department of Experimental, Diagnostic and Speciality Medicine (DIMES) Alma Mater Studiorum Università di Bologna Bologna Italy

2. Dermatology Unit Sant'Orsola‐Malpighi Hospital Bologna Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15327

Reference20 articles.

2. Review of quality of life studies in women with alopecia

3. Alopecia areata and health-related quality of life: a systematic review and meta-analysis

5. Development of a disease‐specific instrument to measure quality of life in patients with alopecia areata;Endo Y;Eur J Dermatol,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells;Healthcare;2024-03-07

2. Higher percentage of CD34+ stem cells and elevated efficacy in androgenetic alopecia treatment observed in CGF prepared from 640 nm laser‐pretreated blood: A preliminary study;Journal of Cosmetic Dermatology;2024-03

3. The Hormonal Background of Hair Loss in Non-Scarring Alopecias;Biomedicines;2024-02-24

4. The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: A randomized controlled trial;Journal of Ethnopharmacology;2024-01

5. Herpes zoster ophthalmicus (HZO) secondary to platelet-rich plasma (PRP) therapy - A case report;Heliyon;2023-12